[APVO] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[APVO] Aptevo Therapeutics Inc.
Announcement Date
18-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -869.96%
Quarter Report
APVO's Result
APVO's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 12,292 4,309 32,424 23,067 14,658 36,434 33,601 -15.41%
PBT -29,408 -30,923 -43,064 -53,689 -55,893 -127,755 -61,337 -11.52%
Tax -2,095 -12,475 -2,616 -2,024 -23,301 -15,340 -2,020 0.60%
NP -27,313 -18,448 -40,448 -53,689 6,973 -112,415 -59,317 -12.11%
Tax Rate - - - - - - - -
Total Cost 39,605 22,757 72,872 76,756 7,685 148,849 92,918 -13.23%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -222.20 -428.13 -124.75 -232.75 47.57 -308.54 -176.53 3.90%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -256.35 -239.38 -610.11 -1,469.88 -941.01 -3,421.45 -1,806.19 -27.75%
EPS Diluted -256.35 -239.38 -610.11 -1,469.88 -941.01 -3,421.45 -1,806.19 -27.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.